GO is a volunteer community of physicians, scientists, designers, engineers, public health experts, policy makers, nurses, lawyers, students, and other professionals working in teams to help people throughout the world who are treating cancer and its related pain.
GO projects are developed and run by highly-skilled volunteers and are mentored by senior volunteers. Current programs and projects are in the areas of advanced training, education, and technology development. GO collaborates with international partners to improve cancer care, research and education in resource-limited settings.
You can mail a check to: Global Oncology | P.O. Box 574 | Brookline MA | 02446
From the Co-Founders
We founded GO in 2012 while we were Hematology/Oncology Fellows at Harvard Medical School. Our objective was to achieve more equitable cancer care in even the most resource-constrained settings by creating and fueling active and dynamic partnerships between skilled professionals around the world with cancer providers in resource-constrained areas. We focused these multidisciplinary teams on solving current, significant problems in access to cancer care.
As we developed GO into the 501(c)(3)* nonprofit organization it is today, we were fortunate to meet many people who shared our goals and formed our volunteer staff. In the short time since we began these efforts, we have grown our volunteer corps to over 100 individuals based in North America and abroad. Together with partners in Malawi, India, Botswana, Rwanda, Haiti, Belize and other countries, we have made great strides towards our shared vision.
Thank you for your interest in our work. We hope you will join us in these efforts.
Ami S. Bhatt, MD, PhD
Assistant Professor, Stanford University
Co-Founder & CEO
Franklin W. Huang, MD, PhD
Instructor, Harvard Medical School
Co-Founder & President
* To be tax-exempt under section 501(c)(3) of the Internal Revenue Code, an organization must be organized and operated exclusively for exempt purposes set forth in section 501(c)(3), and none of its earnings may inure to any private shareholder or individual.